Hepatocyte Period 1 dictates oxidative substrate selection independent of the core circadian clock
Cell Reports · 2024
DOI: 10.1016/j.celrep.2024.114865 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Jiameng Sun und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA. Hauptthemen laut MEDLINE: Circadian Clocks, Hepatocytes, Period Circadian Proteins. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIDDK NIH HHS, NCCIH NIH HHS.
Abstract (Originalsprache)
Organisms integrate circadian and metabolic signals to optimize substrate selection to survive starvation, yet precisely how this occurs is unclear. Here, we show that hepatocyte Period 1 (Per1) is selectively induced during fasting, and mice lacking hepatocyte Per1 fail to initiate autophagic flux, ketogenesis, and lipid accumulation. Transcriptomic analyses show failed induction of the fasting hepatokine Fgf21 in Per1-deficient mice, and single-nucleus multiome sequencing defines a putative responding hepatocyte subpopulation that fails to induce the chromatin accessibility near the Fgf21 locus. In vivo isotopic tracing and indirect calorimetry demonstrate that hepatocyte Per1-deficient mice fail to transit from oxidation of glucose to fat, which is completely reversible by exogenous FGF21 or by inhibiting pyruvate dehydrogenase. Strikingly, disturbing other core circadian genes does not perturb Per1 induction during fasting. We thus describe Per1 as an important mechanism by which hepatocytes integrate internal circadian rhythm and external nutrition signals to facilitate proper fuel utilization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA.
- Department of Chemistry, Washington University in St. Louis, St. Louis, MO 63130, USA; Center for Metabolomics and Isotope Tracing, Washington University in St. Louis, St. Louis, MO 63130, USA; Department of Medicine, W…
- Department of Chemistry and Biochemistry, Central Michigan University, Mount Pleasant, MI 48859, USA; Biochemistry, Cellular, and Molecular Biology Program, Central Michigan University, Mount Pleasant, MI, USA.
- Institute of Microbial Chemistry (BIKAKEN), 3-14-23 Kamiosaki, Shinagawa-ku, Tokyo 141-0021, Japan.
- Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
- Department of Biology, Washington University in St. Louis, St. Louis, MO 63130, USA.
Förderung
- NINDS NIH HHS
- NIDDK NIH HHS
- NCCIH NIH HHS
- NHLBI NIH HHS
- NCI NIH HHS
- NCATS NIH HHS
- Nutrition Obesity Research Center, University of Washington
- American Association for the Study of Liver Diseases
Zitieren
APA
Sun, J., Zhang, Y., Adams, J. A., Higgins, C. B., Kelly, S. C., Zhang, H., Cho, K. Y., Johnson, U. G., Swarts, B. M., Wada, S. I., Patti, G. J., Shriver, L. P., Finck, B. N., Herzog, E. D., & DeBosch, B. J. (2024). Hepatocyte Period 1 dictates oxidative substrate selection independent of the core circadian clock. Cell Reports. https://doi.org/10.1016/j.celrep.2024.114865
Vancouver
Sun J, Zhang Y, Adams JA, Higgins CB, Kelly SC, Zhang H, et al. Hepatocyte Period 1 dictates oxidative substrate selection independent of the core circadian clock. Cell Reports. 2024. doi:10.1016/j.celrep.2024.114865
BibTeX
@article{Sun2024,
author = {Sun, Jiameng and Zhang, Yiming and Adams, Joshua A and Higgins, Cassandra B and Kelly, Shannon C and Zhang, Hao and Cho, Kevin Y and Johnson, Ulysses G and Swarts, Benjamin M and Wada, Shun-Ichi and Patti, Gary J and Shriver, Leah P and Finck, Brian N and Herzog, Erik D and DeBosch, Brian J},
title = {Hepatocyte Period 1 dictates oxidative substrate selection independent of the core circadian clock},
journal = {Cell Reports},
year = {2024},
doi = {10.1016/j.celrep.2024.114865}
}
EUVIMED